Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation

Yong, K, Royle, K-L orcid.org/0000-0003-0225-1199, Ramasamy, K et al. (23 more authors) (2022) Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation. In: Blood. 64th ASH Annual Meeting, 10-13 Dec 2022, New Orleans, Louisiana. American Society of Hematology , pp. 1844-1846.

Metadata

Authors/Creators:	Yong, K Royle, K-L https://orcid.org/0000-0003-0225-1199 Ramasamy, K Parrish, C Hockaday, A Asher, S Drayson, MT de Tute, RM Jenner, MW Kaiser, MF Pratt, G Sive, J Bygrave, C Cook, G Popat, R Smith, D Olivier, C Barnard, L Levinte, D Dawkins, B https://orcid.org/0000-0002-7038-1975 Chapman, MA Chantry, AD Jackson, G Quezada, SA Owen, RG Cairns, D
Dates:	Published (online): 15 November 2022 Published: 15 November 2022
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	14 Jun 2023 16:25
Last Modified:	14 Jun 2023 16:25
Status:	Published
Publisher:	American Society of Hematology
Identification Number:	https://doi.org/10.1182/blood-2022-168842

CORE (COnnecting REpositories)

Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation

Metadata

Download not available

Export

Statistics